Investor / Technology Enthusiast / Company Director
Australia
Joined December 2021
- Tweets20
- Following4
- Followers1
- Likes71
Incredible achievement.
First in Europe #TAVR with ANTERIS DurAVR done at Karolinska. Complex anatomy: Valve-in-valve-in-valve. Impressive hemodynamic result with better flow now than in the original bioprosthesis with this novel balloon-expandable TAVI designed for maximal opening area.
7
First ever #valveinvalve with #duravr was completed with outstanding results under Canada’s Special Access Program, a program where life-saving technology not currently available for commercial use in Canada. #TAVR $avr #tavi
#AnterisTech announces the first #ValveInValve procedure with #DurAVR™ THV has been completed by Dr. Anita Asgar in #Canada as part of Health Canada’s Special Access Program. $AVR #TAVR #TAVI #Innovation #ProudtobeAnteris
Read the Full Announcement: links.anteristech.com/3pz67k…
3
182
Charles retweeted
#Anteristech announces powerful new data from the DurAVR™ THV FIH Study demonstrating sustained haemodynamic performance at 1 year in 12 patients. #TAVR $AVR #TAVI #cardiology #AnterisTech
Read Full Announcement: links.anteristech.com/3MVmdN…
Charles retweeted
Is this the next breakthrough in tissue #TAVR? Congrats @chrismeduri @bapat_savrtavr @SusheelKodaliMD @psorajja on DurAVR 1y data @PCRonline #PCR2023 @EuroInterventio look fwd to EFS! @mirvatalasnag @igeorge1975 @didier_tchetche @djc795 @modine_thomas @esaadi @TsuyoshiKaneko1
The DurAVR transcatheter heart valve was evaluated in a first-in-human study for treating symptomatic severe aortic stenosis. The study demonstrated a good safety profile and promising haemodynamic performance sustained at 1 year. #EAPCI #EUROPCR ow.ly/Lvya50OsBmL
Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve (DurAVR) via @EuroInterventio eurointervention.pcronline.c…
$avr #tavr #tavi #durAVR @AnterisTech
6
184
In addition to undergoing EFS trial of #DurAVR in the #TAVR space, @AnterisTech is also seek to commence development of innovative mitral and tricuspid heart valve repair devices, potentially a $A4.5b market by 2028. $avr
#Anteristech enters partnership with leading physicians to develop innovative mitral and tricuspid heart valve repair devices to treat mitral and tricuspid valve regurgitation – a market expected to be $A4.5 Bn by 2028.
Further details at: bit.ly/41zOCOr
#TEER $AVR
First-in-class biomimetic valve designed to mimic the performance of a healthy human heart valve.
$avr #TAVR #Cardiology
#Anteristech proudly announces the award of a utility patent from USPTO for the design of DurAVR™ THV enhancing IP protection for our novel #TAVR technology.
Congrats to our R&D team on this achievement.
Full details: bit.ly/43kHfMN
#ProudtoBeAnteris $AVR #cardiology
3
241
#DurAVR valve, the next generation one piece valve using @AnterisTech proprietary #Adapt tissue could address the major problems encountered by the existing valve manufacturers.
fiercebiotech.com/medtech/ab…
#TAVR $avr @AbbottNews @Medtronic
TAVI pioneers discuss the past, present and future of transcatheter therapy - Cardiovascular News cardiovascularnews.com/tavi-…
$avr #tavr #durAvr @anteristech
1
72
Wondering if this type of issues could be avoided/mitigated by #DurAVR ?
$AVR #Anteristech #tavr @CEOPaterson
2 year old sapien valve with infective endocarditis causing embolization. Cage was endothelialized into the aorta and the membranous septum making removal challenging. Used the crush technique. @RCubedduMD @GCudemusMD @md_viviana @NCH_Heart #tavr #CardioTwitter #Cardiology
Perhaps the lack of market penetration by the current products may have restricted the true potential of the addressable market of #TARV. Potentially #DurAVR can bring the expected TAVR market in 2025 from 10B to 30B? This is massive. $avr
WATCH: #Anteristech @CEOPaterson on @proactive_au today discussing the recent A$35 million capital raise and upcoming 2023 clinical milestones for the first-in-class, biomimetic #TAVR valve technology, #DurAVR THV
#TAVI #cardiology $AVR #asx #investing #stocks #ProudtobeAnteris
#eurekareport Wayne Patterson, CEO of Anteris, interviewed with Alan Kohler 10 months ago. $avr #TAVR
Anteris Prepares $5 Billion Heart Valve as Suitors Circle eurekareport.com.au/investme…
1
37
Charles retweeted
#Anteristech announces #DurAVR™ Transcatheter Heart Valve (THV) Aortic Stenosis First-in-Human Study results. All performance endpoints met with remarkable hemodynamic function sustained at 12 months.
Full Announcement: ow.ly/CU5h50MrjG6 $AVR #TAVI #TAVR #cardiology
Charles retweeted
#Anteristech CMO @chrismeduri presented Late Breaking Clinical Trial at #PCVLV to a packed audience. At the same time, DurAVR has been approved by the FDA for EFS study. Incredible collaboration by world #TAVR #TAVI authorities pioneering new technology. #proudtobeanteris $AVR
#DurAVR single piece native-shaped valve continues to capture attention. #PCRLV ‘22 showcases the #DurAVR First-in-Human 30-day data as a Late Breaking Trial.
Impressive, novel Cardiac MRI analysis shows DurAVR’s native, human-like performance. #Anteristech #CardioTwitter $AVR
Charles retweeted
Thought provoking #DurAVR BEV #TAVR with 1 piece tissue showing laminar flow in aorta #CMR and large EOA low gradient. Does design & leaflet motion matter? Look fwd to more clinical data. @TCTConference #TCT2022 @chrismeduri @GAilawadiMD @bapat_savrtavr @JoaoLCavalcante @KHERA_MD
#durAVR V Bapat @MHIF_Heart @JoaoLCavalcante
1st AVR to demonstrate restoration of normal flow dynamics ,safe & feasible even in pts w small annulus @rajdoc2005 @adnanalkhouli @JudyHungMD @JGrapsa @purviparwani @hahn_rt @sarano_maurice @mmamas1973 @TCTMD @renujain19 @ASE360
Reporting from channel 9, Anteris Technologies’ groundbreaking innovative 3-D valve to cure aortic valve stenosis disease, proudly made in Australia.
#TAVR #duravr #anteristech $avr #channel9 #australianmade youtu.be/tzruNs5v8LM
Great news for the aortic valve stenosis patients!
If the surgery can bring back your pre-symptom conditions with longer device durability, is that considered a cure rather than a treatment of the disease?
#duravr #tavr $avr
#Anteristech proudly reports 30-day follow-up results on its second cohort of DurAVR patients delivering remarkable clinical improvements.
Read the full ASX announcement: bddy.me/3azebKF
#lastslongerworksbetter #gamechanger #ProudtobeAnteris $AVR #DurAVR #TAVR
1
5
The major advance in Durability of TAVR will benefit the younger patients under 55yo which accounts for over 65k in 2020. $avr #tavr #DurAVR @AnterisTech
SAVR Dominates in Younger Patients, but TAVR's Share Is Growing Fast medpagetoday.com/meetingcove…
